Optimal designs for phase II/III drug development programs including methods for discounting of phase II results (Q5978235)
From MaRDI portal
scientific article
| Language | Label | Description | Also known as |
|---|---|---|---|
| English | Optimal designs for phase II/III drug development programs including methods for discounting of phase II results |
scientific article |
Statements
20
0 references
1
0 references
9 October 2020
0 references
